Ganglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts

Glycobiology

Volumn 18, Issue 8, 2008, Pages 593-601

  Liu, Yihui ^a   Su, Yan ^a   Wiznitzer, Max ^b   Epifano, Olga ^a   Ladisch, Stephan ^a,c  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Cell migration; EGF signaling; Ganglioside; GM3 synthase

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GANGLIOSIDE; GANGLIOSIDE GM3; GANGLIOSIDE GM3 SYNTHETASE; RAC1 PROTEIN; RHO FACTOR; SYNTHETASE;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CARBOHYDRATE ANALYSIS; CASE REPORT; CELL FUNCTION; CELL MIGRATION; CELL MUTANT; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DEPLETION; ENZYME DEFICIENCY; FIBROBLAST CULTURE; GENE IDENTIFICATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; LIPOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SKIN FIBROBLAST;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; GANGLIOSIDES; GENOTYPE; HUMANS; MICE; MUTATION; RAC1 GTP-BINDING PROTEIN; RECEPTOR, EPIDERMAL GROWTH FACTOR; RHO GTP-BINDING PROTEINS; SIALYLTRANSFERASES; SIGNAL TRANSDUCTION;

MURINAE;

EID: 48349105829     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwn039     Document Type: Article

References (36)

1. Chang F, Li R, Ladisch S. 1997. Shedding of gangliosides by human medulloblastoma cells. Exp Cell Res. 234:341-346.
2. del Pozo MA, Alderson NB, Kiosses WB, Chiang HH, Anderson RG, Schwartz MA. 2004. Integrins regulate Rac targeting by internalization of membrane domains. Science. 303:839-842.
3. Etscheid M, Beer N, Dodt J. 2005. The hyaluronan-binding protease upregulates ERK1/2 and PI3K/Akt signalling pathways in fibroblasts and stimulates cell proliferation and migration. Cell Signal. 17:1486-1494.
4. Fishman PH, Max SR, Tallman JF, Brady RO, Maclaren NK, Cornblath M. 1975. Deficient Ganglioside Biosynthesis: A novel human sphingolipidosis. Science. 187:68-70.
5. Go Y, Zhang J, Mi W, Yang J, Han F, Lu X, Yu W. 2008. Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells. Breast Cancer Res. 10:R1.
6. Hakomori S, Yamamura S, Handa AK. 1998. Signal transduction through glyco(sphingo)lipids. Introduction and recent studies on glyco(sphingo)lipid-enriched microdomains. Ann N Y Acad Sci. 845:1-10.
7. Hakomori Si SI. 2002. Inaugural Article: The glycosynapse. Proc Natl Acad Sci U S A. 99:225-232.
8. Handa Y, Ozaki N, Honda T, Furukawa K, Tomita Y, Inoue M, Okada M, Sugiura Y. 2005. GD3 synthase gene knockout mice exhibit thermal hyperalgesia and mechanical allodynia but decreased response to formalin-induced prolonged noxious stimulation. Pain. 117:271-279.
9. Hashiramoto A, Mizukami H, Yamashita T. 2006. Ganglioside GM3 promotes cell migration by regulating MAPK and c-Fos/AP-1. Oncogene. 25:3948-3955.
10. Iwabuchi K, Handa K, Hakomori S. 1998. Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J Biol Chem. 273:33766-33773.
11. Kawai H, Allende ML, Wada R, Kono M, Sango K, Deng C, Miyakawa T, Crawley JN, Werth N, Bierfreund U, Sandholf K, Proia RL. 2001. Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem. 276:6885-6888.
12. Ladisch S, Gillard B. 1985. A solvent partition method for microscale ganglioside purification. Anal Biochem. 146:220-231.
13. Li R, Ladisch S. 1997. Inhibition of endogenous ganglioside synthesis does not block neurite formation by retinoic acid-treated neuroblastoma cells. J Biol Chem. 272:1349-1354.
14. Li R, Liu Y, Ladisch S. 2001. Enhancement of epidermal growth factor signaling and activation of SRC kinase by gangliosides. J Biol Chem 276:42782-42792.
15. Li R, Manela J, Kong Y, Ladisch S. 2000. Cellular gangliosides promote growth factor-induced proliferation of fibroblasts. J Biol Chem. 275:34213-34223.
16. Liour SS, Yu RK. 2002. Differential effects of three inhibitors of glycosphingolipid biosynthesis on neuronal differentiation of embryonal carcinoma stem cells. Neurochem Res. 27:1507-1512.
17. Liu Y, Li R, Ladisch S. 2004. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization. J Biol Chem. 279:36481-36489.
18. Liu Y, McCarthy J, Ladisch S. 2006. Membrane ganglioside enrichment lowers the threshold for vascular endothelial cell angiogenic signaling. Cancer Res. 66:10408-10414.
19. Liu Y, Su Y, Shevchuck N, Epifano O, Wiznitzer M, Ladisch S. 2007. Characterization of Mutant GM3 Synthase Deficient Human Fibroblasts. Glycobiology. 17:1246
20. Maddala R, Reddy VN, Epstein DL, Rao V. 2003. Growth factor induced activation of Rho and Rac GTPases and actin cytoskeletal reorganization in human lens epithelial cells. Mol Vis. 9:329-336.
21. Malliri A, Collard JG. 2003. Role of Rho-family proteins in cell adhesion and cancer. Curr Opin Cell Biol. 15:583-589.
22. Meivar-Levy I, Sabanay H, Bershadsky AD, Futerman AH. 1997. The role of sphingolipids in the maintenance of fibroblast morphology. The inhibition of protrusional activity, cell spreading, and cytokinesis induced by fimonisin B1 can be reversed by ganglioside GM3. J Biol Chem. 272:1558-1564.
23. Ozkara HA. 2004. Recent advances in the biochemistry and genetics of sphingolipidoses. Brain Dev. 26:497-505.
24. Proia RL. 2003. Glycosphingolipid functions: Insights from engineered mouse models. Philos Trans R Soc Lond B Biol Sci. 358:879-883.
25. Ronnov-Jessen L, Villadsen R, Edwards JC, Petersen OW. 2002. Differential expression of a chloride intracellular channel gene, CLIC4, in transforming growth factor-beta1-mediated conversion of fibroblasts to myofibroblasts. Am J Pathol. 161:471-480.
26. Satoh M, Nejad FM, Ohtani H, Ito A, Ohyama C, Saito S, Orikasa S, Hakomori S. 2000. Association of renal cell carcinoma antigen, disialylgalactosylgloboside, with c-Src and Rho A in clustered domains at the surface membrane. Int J Oncol. 16:529-536.
27. Scatchard G. 1949. Attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51:57-74.
28. Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW, Schnaar RL. 1999. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A. 96:7532-7537.
29. Shevchuk NA, Hathout Y, Epifano O, Su Y, Liu Y, Sutherland M, Ladisch S. 2007. Alteration of ganglioside synthesis by GM3 synthase knockout in murine embryonic fibroblasts. Biochim Biophys Acta. 1771:1226-1234.
30. Simpson MA, Cross H, Proukakis C, Priestman DA, Neville DC, Reinkensmier G, Wang H, Wiznitzer M, Gurtz K, Verganelaki A, Pryde A, Patton MA, Dwek RA, Butters TD, Platt FM, Crosby AH. 2004. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet. 36:1225-1229.
31. Tarnawski AS, Jones MK. 1998. The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: Involvement of EGF-R signal transduction pathways. J Clin Gastroenterol. 27 Suppl 1:S12-20.
32. Tatsumi K, Saito M, Lin B, Iwamori M, Ichiseki H, Shimozawa N, Kamoshita S, Igarashi T, Sakakihara Y. 2001. Enhanced expression of a-series gangliosides in fibroblasts of patients with peroxisome biogenesis disorders. Biochim Biophys Acta. 1535:285-293.
33. Walkley SU, Zervas M, Wiseman S. 2000. Gangliosides as modulators of dendritogenesis in normal-and storage disease-affected pyramidal neurons. Cereb Cortex. 10:1028-1057.
34. Wiznitzer M, Wang H, Proukakis C, Cross H, Maxwell K, Gurtz K, Crosby A. 2005. GM3 synthase deficiency: A disorder of ganglioside biosynthesis presenting as an infantile epilepsy. Ann Neurol. 58:S102 (abstract).
35. Yamashita T, Hashiramoto A, Haluzik M, Mizukami H, Beck S, Norton A, Kono M, Tsuji S, Daniotti JL, Werth N, Sandhoff R, Sandhoff K, Proia RL. 2003. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci U S A. 100:3445-3449.
36. Yamashita T, Wu YP, Sandhoff R, Werth N, Mizukami H, Ellis JM, Dupree JL, Geyer R, Sandhoff K, Proia RL. 2005. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc Natl Acad Sci U S A. 102:2725-2730.